Medical Properties Trust, Inc. (NYSE:MPT - Get Free Report) shares saw strong trading volume on Friday. 18,740,309 shares were traded during mid-day trading, an increase of 142% from the average daily volume of 7,753,732 shares. The stock last traded at $2.13 and had previously closed at $2.44.
Key Headlines Impacting Medical Properties Trust
Here are the key news stories impacting Medical Properties Trust this week:
- Positive Sentiment: Management continues to make progress on asset sales, which could generate liquidity and help reduce financial pressure. The stock initially traded higher after the earnings release on optimism surrounding those transactions. Medical Properties trades higher despite Q3 earnings miss amid progress in asset sales
- Neutral Sentiment: Options activity was unusually heavy, with traders purchasing 58,435 call options—about 258% above typical daily call volume. This may indicate speculative bullish positioning, but it does not change the company’s fundamentals.
- Negative Sentiment: Third-quarter normalized funds from operations (FFO) came in at $0.11 per share, below the $0.13 analyst estimate and down from $0.13 a year earlier. Revenue increased 5.3% year over year to $250.14 million, but the revenue and FFO results still missed expectations. Medical Properties Q3 FFO and Revenues Miss Estimates
- Negative Sentiment: Tenant difficulties reportedly prevented payment of September rent, raising concerns about the reliability of Medical Properties Trust’s rental income and its ability to support distributions and debt obligations. Medical Properties Trust Sinks as FFO Misses and Tenant Troubles Precluded Payment of September Rent
- Negative Sentiment: RBC downgraded Medical Properties Trust to Underperform from Sector Perform and reduced its price target to $2 from $4.50, while retaining a speculative-risk designation. The downgrade reinforces investor concerns about tenant exposure, cash flows and execution risk. RBC Downgrades Medical Properties Trust
Analysts Set New Price Targets
MPT has been the subject of a number of analyst reports. Weiss Ratings lowered shares of Medical Properties Trust from a "sell (d+)" rating to a "sell (d)" rating in a report on Tuesday, August 18th. Wells Fargo & Company decreased their price objective on shares of Medical Properties Trust from $5.00 to $3.80 and set an "underweight" rating for the company in a research report on Tuesday, September 1st. Finally, Royal Bank Of Canada downgraded shares of Medical Properties Trust from a "sector perform" rating to an "underperform" rating and decreased their price objective for the company from $4.50 to $2.00 in a report on Friday. Three analysts have rated the stock with a Sell rating. According to data from MarketBeat.com, Medical Properties Trust currently has a consensus rating of "Strong Sell" and a consensus target price of $2.90.
Get Our Latest Research Report on Medical Properties Trust
Medical Properties Trust Stock Performance
The company has a debt-to-equity ratio of 2.16, a current ratio of 3.12 and a quick ratio of 3.12. The stock has a market cap of $1.33 billion, a P/E ratio of -37.00 and a beta of 1.45. The stock has a 50-day simple moving average of $3.45 and a 200-day simple moving average of $4.37.
Medical Properties Trust (NYSE:MPT - Get Free Report) last announced its earnings results on Thursday, October 29th. The company reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.13 by ($0.02). The company had revenue of $250.14 million for the quarter. Medical Properties Trust had a negative return on equity of 0.66% and a negative net margin of 2.96%. Medical Properties Trust's revenue for the quarter was up 5.3% compared to the same quarter last year. Research analysts forecast that Medical Properties Trust, Inc. will post 0.53 earnings per share for the current year.
Medical Properties Trust Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Thursday, October 8th. Shareholders of record on Thursday, September 10th were paid a $0.09 dividend. This represents a $0.36 dividend on an annualized basis and a yield of 16.2%. The ex-dividend date of this dividend was Thursday, September 10th. Medical Properties Trust's dividend payout ratio (DPR) is -600.00%.
Institutional Trading of Medical Properties Trust
A number of institutional investors and hedge funds have recently modified their holdings of MPT. BlackRock Inc. purchased a new position in shares of Medical Properties Trust during the second quarter worth approximately $347,673,000. State Street Corp purchased a new stake in shares of Medical Properties Trust in the 2nd quarter valued at $118,522,000. Allianz Asset Management GmbH bought a new position in shares of Medical Properties Trust during the 2nd quarter valued at $33,903,000. Advisors Capital Management LLC purchased a new position in Medical Properties Trust in the 2nd quarter worth $30,483,000. Finally, Bank of New York Mellon Corp bought a new stake in Medical Properties Trust in the second quarter worth $28,285,000. 71.79% of the stock is owned by hedge funds and other institutional investors.
About Medical Properties Trust
(
Get Free Report)
Medical Properties Trust, Inc is a healthcare-focused real estate investment trust (REIT) that owns and invests in healthcare facilities. Its portfolio has historically included hospitals, inpatient rehabilitation facilities, long-term acute-care hospitals, behavioral health facilities and other properties used by healthcare providers.
Founded in 2003 and headquartered in Birmingham, Alabama, the company primarily generates income by leasing properties to healthcare operators under long-term agreements.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Medical Properties Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medical Properties Trust wasn't on the list.
While Medical Properties Trust currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.